QXO— AI Stock Forecast & Price Targets
Published 7/14/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live QXO price forecast →
QXO is Brad Jacobs' rollup vehicle in building products distribution, and after the TopBuild acquisition and heavy dilution the stock has cratered to $13.87, sitting on 52-week lows with 24.9% short float and a regulatory investigation overhang. Fundamentals show a scaled but unprofitable business (-$632M TTM income, negative FCF -$1.23B) trading at 1.68x sales with a 30.17 analyst target — the setup is a classic deep-value/turnaround wager where technicals are broken but the balance sheet ($3.05B cash) buys time for the M&A thesis to prove out.
Avoid chasing the Kronos bullish forecast — the model's directional accuracy is below naive baseline at both 1d and 1wk horizons, so its snap-back call is not reliable. Price is pinned at the 52-week low ($13.82) with RSI 33.5 and no reversal candle. Prefer to wait for either (a) a reclaim of $15 with volume as confirmation, or (b) a capitulation flush toward $12 with a hammer. If already long, keep size small; invalidation is a clean daily close below $13.50. Do not add on the current bounce hope.
1-6 month view is a coin flip weighted by whether the regulatory investigation resolves benignly and whether Q2'26 earnings (May 12) show integration synergies flowing through. Base case: stock chops $13-$18 as the market digests dilution capacity (4B share authorization) and negative FCF. Bull case toward $22-25 if TopBuild synergies show and shorts (24.9% float) cover. Bear case $10-11 on regulatory escalation or another equity raise. Would change my mind on evidence of positive FCF conversion or a clean SEC resolution.
1-3 year thesis rests entirely on Brad Jacobs replicating his XPO/GXO playbook in the fragmented ~$800B building products distribution market. If the rollup logic works, sub-$14 will look like a gift given the $30 sell-side target and PEG 0.38. The structural risks are (1) building products is cyclical and rate-sensitive — a housing downturn would compress an already-weak margin profile, (2) the 4B share authorization signals more dilution ahead, and (3) integration risk on two large deals executed back-to-back. Long-term holders need multi-year patience and tolerance for -20%+ drawdowns.
Revenue has scaled dramatically via acquisition — Q3'25 hit $2.73B and TTM is $8.56B (Sales Y/Y TTM +15,198% reflects Beacon/TopBuild consolidation), but this is inorganic growth, not underlying demand. Margins are structurally weak: gross 24.6%, operating -11.8%, and the most recent Q1'26 posted -$227M net loss on $1.73B revenue with negative EBITDA of -$59.6M. The balance sheet is the saving grace — $3.05B cash, $3.9B debt (D/E 0.38, current ratio 3.33, $10.16B equity) gives ample runway. However, free cash flow is deeply negative at -$1.23B TTM and Q1'26 FCF was just +$48M, so cash burn from integration and working capital is real. Forward P/E of 19.2x on $0.72 forward EPS assumes a sharp turn to profitability that hasn't been demonstrated yet; PEG 0.38 looks cheap only if you trust that forward number. ROE -6.8%, ROA -0.7% — capital is not yet earning its cost. This is a bet on Jacobs' execution playbook, not on current unit economics.
Every timeframe is broken. On the 1h and 4h charts price has collapsed from ~$18 to $13.87 in a single week, with the print sitting essentially at the 52-week low of $13.82 (RSI 33.5, oversold but not capitulation). Daily chart shows a 6-month downtrend from $27+ in Feb to sub-$14, price is -15% below SMA20, -18% below SMA50, and -30% below SMA200 — a full stack of bearish trend. Weekly view confirms the stock has round-tripped the post-SPAC spike and is now testing the base built pre-run. The Kronos forecast is aggressively bullish across all timeframes (1h target $18.25, 4h $18.63, 1d $19.29), but the model's realized directional accuracy is 31% vs 72% naive baseline on 1d and 50% vs 90% on 1wk — the model is materially worse than random in this regime, so the yellow bands should be heavily discounted. No confirmed reversal signal yet; support is $13.82 and a break opens air below with no visible bid.
The signal here is the July 1 8-K bundling material agreement, M&A completion, executive change, and capital structure items — this is the TopBuild deal closing plus authorization expansion to 4B common shares (Yahoo/SWS coverage confirms Alec Covington joining board, Otero as interim CAO, and new shelf registrations). That's an explicit signal of continued dilution capacity and further M&A. The RBC Outperform ($27 PT) and Citi Buy (lowered $28→$25) provide sell-side cover, and mean analyst target $30.17 with Recom 1.14 (near strong-buy) is unusually constructive versus price action. The offsetting negative is repeated coverage of a regulatory investigation coinciding with the slide — SWS explicitly frames the 55% undervaluation view as now contingent on this resolving. Short float rose from 20.1% to 24.9% in ~45 days, a bearish shift, though it also sets up squeeze potential.
- TopBuild acquisition closed (July 1 8-K, Items 1.01/2.01) — adds insulation installation to roofing/waterproofing distribution stack, cross-sell opportunity into professional contractor base
- Authorized share count expanded to 4,000,000,000 with new shelf registrations filed — explicit optionality for further large M&A in fragmented building products distribution
- Q3'25 revenue of $2.73B vs Q2'25 $1.91B shows Beacon Roofing consolidation is scaling the top line rapidly
- Forward EPS estimate revised up to $131.9% growth (from 124.6%) — sell-side sees an earnings inflection into 2027
- Sell-side consensus target $30.17 with Recom 1.14 and RBC $27 / Citi $25 provides institutional cover for the turnaround narrative
- Cash position of $3.05B and current ratio 3.33 provides runway to execute additional tuck-in acquisitions without immediate equity raise
- Regulatory investigation disclosed in early-July news coverage — resolution unknown, could pressure the multi-year thesis
- Short float 24.9% (up from 20.1% in 45 days) and short ratio 7.76 signals institutional bearish positioning
- TTM free cash flow -$1.23B and Q1'26 net loss -$227M — integration costs are real and profitability is not proven
- 4B share authorization is a Damocles sword — further dilution likely if additional M&A is pursued
- Beta 2.2 and price -30% below 200-day SMA — high volatility and broken trend structure
- Building products distribution is deeply housing-cycle exposed; a rate-driven housing slowdown compresses already-negative operating margins
- Kronos AI forecast is materially unreliable here (1d accuracy 31% vs 72% naive), so the visual bullish band should not anchor expectations
- Retail sentiment 83% bullish on low sample — modest contrarian caution
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord